Valuation: Cegedim

Market Cap 149M 167M 139M 126M 238M 16.1B 240M 1.68B 653M 8.22B 627M 614M 26.41B P/E 2026 *
7.07x
P/E 2027 * 5.91x
Enterprise Value 352M 395M 328M 299M 562M 38.02B 566M 3.96B 1.54B 19.4B 1.48B 1.45B 62.37B EV / Sales 2026 *
0.53x
EV / Sales 2027 * 0.48x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day-10.12%
1 week+6.58%
Current month+6.58%
1 month+16.38%
3 months+15.28%
6 months-3.57%
Current year-9.33%
1 week 11.22
Extreme 11.22
12.15
1 month 10.8
Extreme 10.8
12.15
Current year 8.6
Extreme 8.6
14.8
1 year 8.6
Extreme 8.6
14.8
3 years 8.6
Extreme 8.6
19.6
5 years 8.6
Extreme 8.6
28.6
10 years 8.6
Extreme 8.6
42.5
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 72 09/08/2010
Director/Board Member 55 26/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-10.12%+6.58% - - 167M
+1.48%+3.13%+1.51%+64.45% 3,900B
+0.34%+1.02%+9.44%+1,097.98% 455B
+0.13%+7.45%-50.21%+31.50% 432B
+0.87%+3.74%+96.32%+243.58% 333B
+0.97%+5.18%+122.64%+559.86% 280B
+1.77%+1.54%-18.75%+52.30% 239B
+1.27%+3.52%-25.42%+24.35% 141B
+1.76%+4.42%+114.63%+217.36% 135B
-0.29%+2.87%+82.07%+208.71% 99.25B
Average +0.16%+3.14%+36.91%+277.79% 668.2B
Weighted average by Cap. +1.11%+3.08%+11.71%+177.66%

Financials

2026 *2027 *
Net sales 660M 740M 615M 560M 1.05B 71.26B 1.06B 7.43B 2.89B 36.37B 2.78B 2.72B 117B 683M 766M 636M 579M 1.09B 73.74B 1.1B 7.69B 2.99B 37.64B 2.87B 2.81B 121B
Net income 21.45M 24.04M 19.98M 18.19M 34.25M 2.32B 34.5M 241M 93.95M 1.18B 90.26M 88.32M 3.8B 25.57M 28.66M 23.82M 21.68M 40.82M 2.76B 41.12M 288M 112M 1.41B 108M 105M 4.53B
Net Debt 203M 228M 189M 172M 324M 21.92B 327M 2.29B 889M 11.19B 854M 836M 35.96B 178M 200M 166M 151M 284M 19.22B 286M 2B 780M 9.81B 749M 733M 31.54B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,487
Date Price Change Volume
29/04/25 EUR 12.15 -56.91% 120
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.86EUR
Average target price
15.13EUR
Spread / Average Target
+39.35%

Quarterly revenue - Rate of surprise